In vivo maturation and migration of dendritic cells
Year: 2001
Type: review
Abstract: The hallmark of immunity is antigen (Ag) recognition. From early life until death we face countless Ags; many are deleterious and come from the outside world. However, lymphocytes, the mediators of specific acquired immunity, are usually not exposed where foreign antigens are encountered. Thus a system must ferry these Ags from the periphery into inner tissues where lymphocytes comfortably reside or traffic. Clearly, translocating Ags from the periphery to the lymphoid niches is a pivotal function whereby the dendritic cell (DC) system initiates immune responses. DCs, however, are not passive Ag couriers; a dynamic process not fully understood is triggered by Ag deposition. Strategically poised at the boundaries between the inner and the outside world, in a way bridging innate and acquired immunity, DCs sample, trap, engulf, and digest Ags of very diverse origin, in what is called Ag processing. Antigenic fragments are then regurgitated, exposed at the cell surface through one of three molecular pathways [Major histocompatibility complex (MHC) CI and CII, and CD1)] responsible for an efficacious Ag presentation. Concomitantly, DC bear an arsenal of powerful costimulatory molecules [CD40; CD80; CD86; DC-specific/intercellular adhesion molecule type 3-grabbing, non-integrin (DC-SIGN)] and the potential to produce critical cytokines [chemokines, interleukin-12 (IL-12), etc.], thus ensuring the initiation and the fate of acquired immunity. The DC system is particularly efficient, not just translocating, but also transforming antigens sampled at the earlier local milieu into an immunologically accesible language, becoming an excellent reporter of the previous antigenic past, translating the conundrum posed by viruses, bacteria, proteins, etc., into T-cell receptor (TCR) ligands; a short-peptide vocabulary that T cells especially now understand. A highly dynamic process is thus triggered by encountering Ags; while these are carried and processed to be appropriately presented, DCs in turn experience a variety of changes: migratory, phenotypical, functional; all encompassed in the term maturation. Essentially, DC maturation means to change from an antigen-capturing to an antigen-presenting, T-cell-priming mode, a process whereby DCs convert antigens into efficacious immunogens, express the necessary cytokines and costimulatory molecules, thus appropriately initiating the specific, acquired clonal immunity. Though the term DC lineage has been loosely used, that seems changing to a multilineage concept, as, for instance, different DC types can be generated from a variety of different progenitors and precursors.1 With the exception of FDC that are located exclusively within follicles and do not seem to traffic,2 all DC types known are BM derived. However, the potential mechanisms controlling the production of DC or their progenitors within BM, are not known. Nor it is known whether these putative controls are autonomous, exclusive of BM, or dependent on exogenous-paracrine influences, or even affected by external environmental stimuli like microbial products. For instance, the daily BM production of DC, of DC progenitors or precursors, as well as their subsequent release into the blood stream, is virtually unknown. Certainly, however, DC circulating in blood are scarce (less than 1%), but given the ceaseless steady-state DC traffic between blood, lymph and tissues,3 a constant BM supply of DC or DC precursors is assumed. Research into when during ontogeny, or under which mechanisms of control, DC or DC precursors colonize peripheral tissues like intestine, skin, respiratory airways or the genital mucosa, is scarce. Nor it is known whether developmental synchrony exists both for colonizing the periphery and for phenotype maturation. In mouse skin for instance, epidermal DC are present in newborns at day 0, but with the exception of adenosine triphosphatase (ATPase) and CD45, they lack most adult markers (Heras M, manuscript in preparation), which appear later. Also, it is not known whether these DC in newborns will perform any of the various functions that their adult counterparts do (Fig. 1). Dendritic cell (DC) system without antigens (Ags). 1 Haemopoietic pluripotential cells (HPC) under as yet unknown influences constantly generate dendritic cell (DC) progenitors, which, likewise, 2 generate DC precursors. 3 These enter the blood stream and, together with circulating monocytes (Mn), Mn from the blood marginating pool (BMP), and plasmacytoid precursors, constitute the potential largest reserve of blood DC precursors. 4 By undefined mechanisms, precursors and DC leave the blood to colonize peripheral tissues (skin, intestinal, genital and airways epithelia) as sentinel immature DC. 5 In absence of exogenous Ag there is a constitutive 'steady-state' flux toward lymphatics, some DC carry apoptotic remains from fraternal cells, and some Mn might be stationed at the abluminal side and reverse transmigrate into lymphatics. 6 Lymph-derived DC congregate in T-cell zones or paracortex, presumably exposing self-Ags without costimulators, and peripherally tolerizing self-reactive lymphocytes (Lc). Plasmacytoid precursors leave blood through HEV and, if encountering appropriate signals (CD40L, IL-3) become DC localizing in T-cell zones and probably inside germinal centres (GCDC). Meanwhile, T cells specific for exogenous Ag remain naive (TN) and continue trafficking unaltered. 7 Presumably, a big proportion of apoptotic DC death occurs here by as yet unknown mechanisms, but likely the outcome of at least Fas–Trance–CD40L interactions. Whether senescent DC 'retire' and remain here, and for how long, is also unknown. 8 Some DC might exit lymph nodes (LN) and start a still undefined pathway to recirculate. Concomitantly, unperturbed T cells continue recirculating, still in a naive stage. (MHC CII, dark-green colour.) Classical experiments suggest that in skin, for instance, the turnover of epidermal DC is of several weeks in the steady state. When labelled thymidine is administered to mice during five days, no epidermal DC are marked,4 whereas most DC in mesenteric lymph are labelled, implying a more rapid turnover of the latter cells. Furthermore, prolonged survival of DC has been documented in skin transplants, for as long as 6 months.4 Of note, resident DC in the respiratory tract decline substantially within 3 days of irradiation, and BM reconstitution indicates a half life of about 2 days, comparable to that proposed for gut wall DC.5 Holt thus suggests that DC in mucosal sites have shorter replenishment times than in tissues such as the skin. Recently, Matsuno and colleagues6 described hepatic DC in an immature, postmitotic end-stage, which, according to BrdU feeding have been recently generated. These cells ingest particulate material, translocate from blood to lymph localizing in the T-cell zone of celiac nodes, and their monocytic origin is implied.6 Nevertheless, it would appear that once in the periphery, DC become terminal cells unable to divide, as DC in draining lymph nodes (DLN) and most tissues seem radioresistant,7 and no mitotic figures of tissue DC have ever been described.7 Though in vitro several cell types can generate DC, perhaps the more abundant potential source of BM-derived DC precursors in vivo are blood monocytes, as their in vitro treatment with granulocyte macrophage–colony-stimulating factor (GM–CSF) and IL-4 rapidly generates functional DC.8 Further in vitro experiments showed that in apparent absence of these cytokines, phagocytosing monocytes differentiate into DC while reverse-transmigrating endothelium toward the lumen,9 reminiscent of DC moving into lymphatics. Initial experiments in monocyte-deficient op/op mice implied that the relative contribution of this potential pathway might not be affecting the overall DC status in vivo, as these animals have readily detectable DC in skin, spleen, lymph nodes and Peyer's Patches, despite the severe monocyte deficiency.10 However, a re-examination of these op/op mice studies revealed that the acquisition and presentation of particulate antigens in vivo, such as subcutaneously injected microspheres, might define a population of monocyte-derived DC responsible for these discrete functions.11 Another potential source of circulating DC precursors is the human plasmacytoid cell type,12 apparently identical to the natural interferon-α/β (IFN-α/β) -producing cells (IPC).13,14 Under viral stimulation, IPC become DC inducing IFN-γ and IL-10 production by T cells.14 However, when cultured with CD40-ligand (CD40L) and IL-3, these cells become functional 'type 2' DC, the putative human lymphoid-derived DC, which seems to skew T-cell responses toward T helper type 2 (Th2) polarization.15 Circulating plasmacytoid monocytes also produce large amounts of type I IFN but, unlike DC, enter inflammed lymph nodes from blood through high endothelial venules (HEV).16 The propounded counterpart DC 'type 1', deemed the monocyte-derived DC, shifts T-cell responses toward Th1.15,17 It has been recently argued that the same DC population has the plasticity to lead to both T helper polarizations, depending on the DC stage.1,18 In any case, an important number of monocytes are in the blood marginating pool, constituted by microvasculatures of liver and spleen where blood flow is substantially slow. They represent good candidates for blood DC precursors in vivo, especially as particulate materials can be ingested at these locations.7 A fundamental achievement in DC research was their in vitro production, either from pluripotential progenitors19,20 or monocytes8 treated with GM–CSF, generating a prevailing belief that this cytokine was indispensable to produce DC in vivo. However, genetically manipulated animals lacking GM–CSF,21 or its receptor,22 soon proved otherwise as these mice exhibited other anomalies, but were able to develop apparently normal DC. Other genetically altered animals such as RelB–/–23 and transforming growth factor-B (TGFB–/– mice24 did reveal alterations in the DC system, as the former has Langerhans cells (LC) but not fully mature splenic DC, whereas the latter lacks epidermal LC,24 implying at least differential pathways during in vivo DC ontogeny. Studies in OX40Ligand–/– mice have recently uncovered that peripheral DC might be defective only at a defined stage of their functioning. These mice exhibited an impaired contact hypersensitivy (CHS) response, apparently due to a defective DC performance during the induction of T-cell priming, but not during the challenge phase.25 In contrast, cutaneous and lymph node DC from Rag 2–/– mice seem functionally defective both in the induction and the elicitation phase, and their functional maturation seemed dependent on the presence of normal T cells.26 Likewise, Ikaros mutant mice27 as well as athymic animals have also revealed alterations within the DC system,26 though less well characterized. Once an Ag overcomes barriers such as the skin stratum corneum, mucus, genital secretions, etc., it will then encounter other ones such as epithelial cells, monocytes, and probably DCs. Given their anatomical location, many cell types like epithelial cells of the genital tract or keratinocytes in skin might encounter incoming Ags; however, only some are capable of performing the next steps toward immunity: Ag uptake and degradation. While some cells might have these latter abilities, only few will be able to continue up to Ag processing. Even further on, very few cell types will have the ability to do what is required next: directed migration toward lymphoid tissues. The culmination of this process initiated by peripheral Ag deposition will be: (a) the non-random accumulation of these Ag-ferrying and processing cells in the paracortex and T-cell areas of peripheral lymphoid tissues, (b) the phenotypic and functional switch in DC from an Ag-sampling to an Ag-presenting T-cell priming stage, and (c) the intimate clustering of DCs with a matched, low-frequency Ag-specific clone, a phenomenon deemed the immunological synapse (Fig. 2). Dendritic cell (DC) system with antigens (Ags). 1 Haemopoietic pluripotential cells (HPC) presumably increase production of DC progenitors and, 2 DC precursors, 3 augmenting influx to blood of DC precursors, of Mn DC precursors from the BMP and, depending on the Ag (viral), of plasmacytoid DC precursors also. Activated endothelium is now able to interact with scarce circulating DC, perhaps facilitating their egress. 4 Encountering Ags (red colour) in peripheral tissues are likely to be accompanied by microbial products (lipopolysaccharide, LPS) and early proinflammatory molecules (interleukin-1, IL-1; tumour necrosis factor, TNF; CD40-ligand, CD40L). 5 All these events concur to differentiate DC precursors and activate peripheral immature DC. These downregulate molecules holding them locally (E-cadh) and crawl toward lymphatics using MDR1, integrins and chemokine receptors to move and orientate themselves. Some abluminal Mn become DC while phagocytosing and reverse migrating to the lumen, while lymphatics upregulate molecules (adhesion molecules, SLC) helping DC to navigate to lymphoid tissues. 6 Whether the bifurcation for Ag-bearing DC to enter follicles or to congregate outside in the T-cell zones is simply stochastic, is unknown. Mobilized maturing DC downregulate phagocytosis, increase costimulators (CD40, CD80, CD86) as well as the proportion and time of Ag (red)–MHC (dark green) complex exposure. They also produce chemokines attracting naive (DC-CK1) and activated (MDC) T cells, facilitating (DC-SIGN) intimate encounters with low-frequency specific naive T lymphocytes, which scan their membranes during the immunological synapse. If Ag is of viral origin, presumably more plasmacytoid-derived DC are produced, some localizing within GC. In the medullary cords, other DC associate with plasmablast rescuing them from apoptosis. 7 DC fate afterwards is unclear. Presumably, most DC subsets die here by apoptosis, perhaps the outcome of tight clustering with strongly activated (FasL-expressing) T cells and the interplay between Fas, CD40L and TRANCE. Whether putative senescent DC survive, and if they do, for how long, and how they die, remains unkown. 8 T cells emerge activated (T act) to recirculate through blood and tissues becoming effector cells, and DC-rescued plasmablasts become Ab-producing cells. 9 Certain activated T cells will be homing in to the sites of their initial Ag encounter, mounting a response there. It is unclear whether matured Ag-bearing or senescent DC recirculate and how. (Exogenous Ag, red colour; MHC CII, dark green colour.) Though substantial work has been done on DCs recently, the very early steps ensuing Ag encountering in vivo are mostly unkown, especially regarding the initial DC mobilization. Nevertheless, most of the knowledge derives from skin DCs, either murine or from human skin explants. Early after applying contact sensitizers, several proinflammatory cytokines are induced locally, especially IL-1 and tumour necrosis factor-α (TNF-α).28 Interfering with TNF-α has revealed that this is a key cytokine for the initial Ag-triggered DC mobilization.29 For instance, animals lacking TNF receptor have defective DC migration;30 anti-TNF Abs inhibit both delayed-type hypersensitivity (DTH) reactions31 and mobilization of DC from the periphery into lymph32 and DLNs.29 Conversely, cutaneous TNF application induces migration of peripheral DC into DLNs.33,34 As at least in skin this occurs within minutes of Ag contact, a cellular source with preformed ready-to-use TNF is inferred. Mast cells are good candidates, as, in addition to their location at mucosae and skin and their early involvement in inflammation, they bear important molecules that can affect DC mobilization, maturation and survival, such as TNF, IL-4 and CD40-ligand.35 Recently, the p-glycoprotein, MDR1, was implicated in the early mobilization of skin LC, as these remained in the epidermis when using an MDR1 antagonist in skin explant cultures.36 It has also been shown that E-cadherin on DC, by to locally to early DC mobilization from E-cadherin on seems to be one of the signals in this DC to from their cutaneous to start to lymphatics. Likewise, most epidermal LC, but not lymph node DC, express is in the of lymphatics and lymph node (LN) the and the induced migration from as well as the of DC into are with However, while epidermal DC from keratinocytes and a as if to they did not leave the after skin or in vivo stimulation, non-random of DC appear within putative lymphatics, both in human and mouse work in mice has also shown that this chemokine receptor seems required for the DC to from into the apparently the of in vivo DC migration to a was recently the of human exhibited defective mobilization of epidermal DC into the with a is perhaps the DC in vivo, especially in the of Ag exposure. The mice uncovered an apparently of IL-10 epidermal DC migration during Ag as these animals DC traffic into and a Nevertheless, the earlier steps from epidermis into are not fully understood It is also unknown whether DC mobilization into lymphatics, steady or is a passive phenomenon due to the of the of these Nor it is known whether the DC trafficking under steady-state is the same population Ag or a DC this of chemokines and adhesion molecules a of traffic signals that DC to navigate through different tissues. In vitro studies have shown that DC to immature peripheral DC bear functional chemokine receptors of an whereas mature DC switch these receptors to what is called a response DC the and on a activated endothelium and DC blood toward inflammed tissues. In the Peyer's Patches, DC toward mucosal whereas lymphoid DC into the T-cell Also, but not upregulate lymphoid tissue chemokine is both in endothelium and in lymphoid thus the initial to DC lymphatics on their way to the paracortex (Fig. 2). Studies in animals have revealed the involvement of cytokines such as in the lymphoid tissue However, it is that DC within lymphoid tissues, by of the variety of chemokines they can might have discrete the of T and cells in lymphoid tissues. In DC have been shown to be in the of lymphoid tissue during the induction and of such as these are especially when highly intimate clustering between DC and lymphocytes are this will a phenomenon described as or to the in from lymph nodes Ag DC have been shown to produce a large of chemokines in vitro on T-cell and and chemokine to congregate T cells and plasmablasts in and cells in vivo and in during The chemokine chemokine (MDC) for instance, is during in vivo maturation and migration of epidermal into the from was very good at attracting activated but not naive T cells, whereas the chemokine in by DC in the paracortex and germinal is for naive T the molecule functions on DC adhesion on naive T cells, the exclusive DC to activate naive T differential of defined molecules and chemokines by DC subsets within lymphoid tissues, by attracting naive or activated T cells, will contact with Ag-specific T-cell whether for a or a immune While most studies T-cell by DC, is known regarding DC cells. is as DC and mature Ag remains of Ag might be for in vitro and in vivo that DC might affect naive cells to become cells, thus the priming of responses For instance, an in vivo of proved highly to rapidly in a Though human naive cells have been in to DC in the for instance, is naive priming, that given the few for this and T to and activated DC might be to all signals seems by earlier when DC from cells Furthermore, the tissue origin of DC, but not of T cells, not only the but also the of in the other in vivo work from indicates that an apparently different DC located at the medullary and not with T cells might be responsible for plasmablast and survival, thus production Also, in vivo work from has DC type that early after cutaneous not in the paracortex but within and, in vivo into naive induces it is not yet if DCs Ag into the paracortex are the same population this same Ag into or it is known whether Ag is simply the of DC in or both as well as or is a yet to be (Fig. 2). from cytokines, exogenous products such as can DC from the to lymph when administered and to increase DC mobilization from tissues such as and It is not known whether products from from or from might also affect in vivo DC or survival, an under it would that and exogenous products such as, for TNF-α and as of both migration and maturation of DC, as they are likely to be present at the early during Ag exposure. DC appear to to Ag processing. For instance, stimuli are with the key in DC from an immature to a mature Ag-presenting stage. seems dependent on substantially the as well as the of MHC these latter phenomenon apparently from and of MHC However, more revealed that the relative of immature DC to present Ag apparently from a in the of MHC CII, a in a DC to stimuli like and As DC mature in lymphoid tissues, MHC the will for at the thus T-cell more to DC in of Ags of the same DC molecules such as and will be both in vitro and in The counterpart is that in human and murine peripheral immature DC lack costimulatory molecules such as CD80, and and MHC is mostly Ag apparently for times within lymphoid tissues. the time of surface Ag on maturing DC has been described as antigenic as the previous antigenic of DC now remain It is likely that most of these Ags will be from the of Ag encounter, probably to and to microbial products While in most DC appear to from in the respiratory tract airways DCs are apparently the cells into the local Ag only by the to this DC influx into the there is an DC traffic into the draining lymph These experiments also showed that to these DC immature DC from liver also an migration in to blood from the to It is known from early work that there is a ceaseless migration of DCs through lymph at a of about of exogenous Ag which is several times Ag However, as the of skin DC their the DC circulating in other yet unknown are work has shown that these constantly migrating immature DCs might be apoptotic cells from the periphery into the draining lymph nodes, likely from turnover in these phenomenon was in and for apoptotic epithelial cells in A is that self-Ags from apoptotic cells will be and to lymphocytes by immature DCs, thus inducing of immunity fraternal A is that the latter will the to exogenous it in a for when this Ag encounter is scarce research about the fate of DC once they have specific, acquired immune responses within lymphoid tissues. For instance, has shown in vivo unlike DC, DC many Ag-specific T cells but from in about the number of DC with to the number of DC through lymph it is that most DC must die inside lymph nodes, they into the blood flow or become into of there are no for either of these have been proposed as the for DC. however, there is no for this latter the between DC and Certainly, apoptotic cell death in vivo and in has not even in where is deemed to It is still then that the DC death inside is not readily of such as a apoptotic during or perhaps cell type the as seem to do with apoptotic cells within Even in vitro there is work DC apoptosis, either on the potential signals to it irradiation, or to it chemokine In vitro experiments suggest that whereas putative immature DC that have not yet with T cells are more to Fas, DC that have the CD40-ligand of T cells become While this might the of DC during the intimate synapse with strongly activated T cells, thus ensuring early T it the as to how T-cell and when the DCs It has even been that the of DC within lymphoid tissues after an immune response be with the of T-cell as the mechanisms to the latter are not well understood the research on DCs recently, there remain to be especially within the in vivo For instance, the mechanisms whereby BM a constant supply of DC progenitors, whether these mechanisms are exclusive or by as diverse as, for instance, or microbial products. is work on the of DC in vivo, especially regarding the phenotype and the of peripheral tissues, which be to a of Likewise, more of DC mobilization from skin, intestine, airways and genital in the of and and The involvement of DC both in and as well as the putative DC death within lymphoid tissues, also Another to be is the system whether for DC subsets or for potential controls DCs, as shown for epidermal A is the between the DC subsets described in vitro and one and their in vivo and in for instance, like epidermal seem to DC subsets in vivo their maturation pathways be an in their molecular and be a to potential Some perhaps be in of the knowledge of the DC DC involvement in whether from or and is a as recently must to immunity. I would like to to this work in different especially and is to the of life to by
Source: Immunology
Author: Leopoldo Flores‐Romo
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: dendritic cells, dendritic cell maturation, dendritic cell migration, antigen processing, antigen presentation, costimulatory molecules, MHC class I and II, T cell priming, dendritic cell lineage, dendritic cell precursors, chemokines, IL-12, innate and adaptive immunity, lymphocyte homing
Open Access status: green
OpenAlex ID: W2169472881
